Biocon
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
20th km Hosur Road Electronic City, Wipr...Phone Number
+91 8028082808Website
www.biocon.comRevenue
$1.8 BillionStock Symbol
BIOCON.NSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Biocon
Biocon Limited is India’s largest and most prominent biopharmaceutical company, specializing in the development and manufacture of high-quality, affordable medicines for chronic conditions. Headquartered in Bangalore and founded by Kiran Mazumdar-Shaw in 1978, the company has evolved from an enzyme manufacturer into a fully integrated global biopharma leader. Biocon operates through four key strategic business units: Generics (APIs and formulations), Biosimilars (via Biocon Biologics), Novel Biologics, and Research Services (via its subsidiary, Syngene). The company is a global leader in biosimilar insulins and monoclonal antibodies, particularly in oncology, diabetes, and immunology. As of 2026, Biocon remains at the forefront of the "GLP-1" peptide market and continues to expand its reach across 120+ countries, driven by a mission to provide equitable access to life-saving healthcare for a billion people.Explore more
Biocon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biocon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Biocon recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Biocon had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Biocon has new funding data
Congratulate Masked Content for being promoted to Masked Content at Biocon
Biocon, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biocon is spiking on competitors!
Check if Biocon has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Biocon launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Biocon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biocon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biocon.
Biocon financials insights
Gather financial insights about Biocon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$30M
Other Financing Round
$150M
2021
Other Financing Round
$75.5M
Biocon Tech Stack
A closer look at the technologies used by Biocon
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Promotion
Executive Move
Executive Moves, Promotion
Person-Based
Executive Moves, HR Operations, Talent Management
Promotion
Executive Move
Executive Moves, Promotion
Biocon News & Media
Biocon Names Mandar Ghatnekar as Chief Technology Officer - CXO Digitalpulse
Mandar Ghatnekar has been appointed as Chief Technology Officer at Biocon. In this role, he will lead the company’s technology strategy, focusing on advancing digital capabilities and strengthening innovation across its operations. Ghatnekar transitions into this position from Biocon Biologics, where he served as Global Head of IT & Digital Transformation. During his tenure, he […]How Recent Shifts Are Reframing The Biocon (NSEI:BIOCON) Investment Narrative
Biocon’s fair value estimate has been adjusted slightly, moving from ₹421.60 to ₹420.74, a change of less than 1% that keeps the price target broadly in line with earlier expectations. Analysts largely view this as fine tuning of their models rather than a major reset, with debate centering on what could support upside and what might limit near term returns. Read on to see how to interpret this update and what to watch as theManinder Kapoor Puri exits Biocon, joins Syngene as CHRO - HR Katha
In her new role, Puri will lead HR for a workforce of over 5,500 scientists and professionalsNaveen Narayanan to be CHRO, Biocon - HR Katha
Naveen Narayanan picked for CHRO role at Biocon; Since 2021, he has been serving as global head – HR, Biocon Biologics, its subsidiary.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Biocon
Sign Up For FreeTo access detailed company insights
Biocon Limited is India’s largest and most prominent biopharmaceutical company, specializing in the development and manufacture of high-quality, affordable medicines for chronic conditions. Headquartered in Bangalore and founded by Kiran Mazumdar-Shaw in 1978, the company has evolved from an enzyme manufacturer into a fully integrated global biopha... Read More
